nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer
|
Frasca, M. |
|
2018 |
90 |
C |
p. 10-18 |
artikel |
2 |
A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial
|
Bouman-Wammes, Esther W. |
|
2018 |
90 |
C |
p. 1-9 |
artikel |
3 |
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas
|
Delahousse, Julia |
|
2018 |
90 |
C |
p. 83-91 |
artikel |
4 |
Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy
|
Godillot, C. |
|
2018 |
90 |
C |
p. 142-145 |
artikel |
5 |
Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]
|
Gnekow, Astrid K. |
|
2018 |
90 |
C |
p. 156-157 |
artikel |
6 |
C-statistic: A brief explanation of its construction, interpretation and limitations
|
Caetano, S.J. |
|
2018 |
90 |
C |
p. 130-132 |
artikel |
7 |
Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma
|
Spoerl, Silvia |
|
2018 |
90 |
C |
p. 26-33 |
artikel |
8 |
Mammography screening: A major issue in medicine
|
Autier, Philippe |
|
2018 |
90 |
C |
p. 34-62 |
artikel |
9 |
Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab
|
Rogatsch, Max |
|
2018 |
90 |
C |
p. 146-148 |
artikel |
10 |
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients
|
Verly, I.R.N. |
|
2018 |
90 |
C |
p. 102-110 |
artikel |
11 |
Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study
|
Dackus, G.M.H.E. |
|
2018 |
90 |
C |
p. 92-101 |
artikel |
12 |
Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27
|
Strasser-Weippl, K. |
|
2018 |
90 |
C |
p. 19-25 |
artikel |
13 |
Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancer
|
Miles, David |
|
2018 |
90 |
C |
p. 153-155 |
artikel |
14 |
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
|
Haag, G.M. |
|
2018 |
90 |
C |
p. 122-129 |
artikel |
15 |
Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma
|
Franke, Viola |
|
2018 |
90 |
C |
p. 149-152 |
artikel |
16 |
Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis
|
Anderson, Jana J. |
|
2018 |
90 |
C |
p. 73-82 |
artikel |
17 |
The Danish Head and Neck Cancer fast-track program: a tertiary cancer centre experience
|
Roennegaard, Anders B. |
|
2018 |
90 |
C |
p. 133-139 |
artikel |
18 |
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
|
Van Cutsem, Eric |
|
2018 |
90 |
C |
p. 63-72 |
artikel |
19 |
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
|
Guo, Y. |
|
2018 |
90 |
C |
p. 111-121 |
artikel |
20 |
When politicians really decide that nation health is a top priority: the Danish model
|
Hamoir, Marc |
|
2018 |
90 |
C |
p. 140-141 |
artikel |